A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely ...

The visible symptoms only scratch the surface of this chronic skin condition Living with a chronic condition like atopic ...

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission.

Medically reviewed by William Truswell, MD Atopic dermatitis (the most common form of eczema) causes dry, itchy skin, often ...

Dupilumab treatment of atopic dermatitis resulted in long-term skin improvements linked to changes in skin’s the molecular composition.

In this video, Peter Lio, MD, highlighted research from the American Academy of Dermatology meeting and said his biggest takeaway from the meeting was that dermatologists are in “the decade of atopic ...

In this video, Peter Lio, MD, discussed updates on topical agents, biologics and drugs in the pipeline in atopic dermatitis from presentations at the American Academy of Dermatology meeting.

“My boss told me to go to the ER immediately.” So she did. At the ER, the doctors said it looked like atopic dermatitis, or eczema, but instructed her to see a dermatologist to know for sure.

That translates to clinically impetiginized atopic dermatitis as well. How this gets initiated. We're not there yet. Different models of research show that it could be that Staph aureus precedes ...

There’s a link between what you eat and skin flares due to atopic dermatitis, aka eczema. And it’s personal. "Unfortunately, there’s no one-size-fits-all eating pattern that would help ...

Looking for reliable medications to treat 'Atopic Dermatitis'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.